프레가발린 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "프레가발린" in Korean language version.

refsWebsite

Global rank Korean rank

2^nd place

3^rd place

4^th place

1^st place

68^th place

145^th place

399^th place

141^st place

6^th place

18^th place

archive.org

Randinitis, Edward J.; Posvar, Edward L.; Alvey, Christine W.; Sedman, Allen J.; Cook, Jack A.; Bockbrader, Howard N. (2003). “Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal Function”. 《The Journal of Clinical Pharmacology》 43 (3): 277–83. doi:10.1177/0091270003251119. PMID 12638396.

Bockbrader, H. N.; Wesche, D.; Miller, R.; Chapel, S.; Janiczek, N.; Burger, P. (2010). “A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin”. 《Clinical Pharmacokinetics》 49 (10): 661–669. doi:10.2165/11536200-000000000-00000. PMID 20818832.
Hantson, P; Courtois, F; Borrey, D; Haufroid, V (2014). “Pregabalin-associated myoclonic encephalopathy without evidence of drug accumulation in a patient with acute renal failure”. 《Indian Journal of Nephrology》 24 (1): 48–50. doi:10.4103/0971-4065.125102. PMC 3927193. PMID 24574633.
Randinitis, Edward J.; Posvar, Edward L.; Alvey, Christine W.; Sedman, Allen J.; Cook, Jack A.; Bockbrader, Howard N. (2003). “Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal Function”. 《The Journal of Clinical Pharmacology》 43 (3): 277–83. doi:10.1177/0091270003251119. PMID 12638396.
Schifano, Fabrizio (2014). “Misuse and Abuse of Pregabalin and Gabapentin: Cause for Concern?”. 《CNS Drugs》 28 (6): 491–6. doi:10.1007/s40263-014-0164-4. PMID 24760436.

“Summary of product characteristics” (PDF). European Medicines Agency. 2013년 3월 6일. 2018년 9월 16일에 원본 문서 (PDF)에서 보존된 문서. 2013년 5월 6일에 확인함.

Bockbrader, H. N.; Wesche, D.; Miller, R.; Chapel, S.; Janiczek, N.; Burger, P. (2010). “A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin”. 《Clinical Pharmacokinetics》 49 (10): 661–669. doi:10.2165/11536200-000000000-00000. PMID 20818832.
Hantson, P; Courtois, F; Borrey, D; Haufroid, V (2014). “Pregabalin-associated myoclonic encephalopathy without evidence of drug accumulation in a patient with acute renal failure”. 《Indian Journal of Nephrology》 24 (1): 48–50. doi:10.4103/0971-4065.125102. PMC 3927193. PMID 24574633.
Randinitis, Edward J.; Posvar, Edward L.; Alvey, Christine W.; Sedman, Allen J.; Cook, Jack A.; Bockbrader, Howard N. (2003). “Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal Function”. 《The Journal of Clinical Pharmacology》 43 (3): 277–83. doi:10.1177/0091270003251119. PMID 12638396.
Schifano, Fabrizio (2014). “Misuse and Abuse of Pregabalin and Gabapentin: Cause for Concern?”. 《CNS Drugs》 28 (6): 491–6. doi:10.1007/s40263-014-0164-4. PMID 24760436.

“Summary of product characteristics” (PDF). European Medicines Agency. 2013년 3월 6일. 2018년 9월 16일에 원본 문서 (PDF)에서 보존된 문서. 2013년 5월 6일에 확인함.